Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results. 2019

Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
Department of Urologic Surgery, Tianjin Medical University Second Hospital, Tianjin, China.

OBJECTIVE This study sought to identify factors associated with survival of pT1 urothelial carcinoma of bladder (UCB) after radical cystectomy (RC). METHODS This study consists of 114 pT1 UCB [primary 83, recurrent 31, none were amenable to transurethral resection (TUR)] treated by radical cystectomy. Survival analysis using Cox regression tests were performed to identify factors associated with survival of pT1 UCB after RC. RESULTS Pelvic lymph node (LN) status, age and lymphovascular invasion (LVI) are associated with survival of pT1 UCB after RC; recurrent pT1 UCB of high grade origin (HGO) tends to have poorer CSS than primary pT1 UCB or recurrent pT1 UCB of low grade origin (LGO) (5-year and 10-year CSS rates was 75% and 73% for primary cases; 77% and 77% for recurrent pT1 UCB of LGO; and 56% and 37% for recurrent pT1 UCB of HGO, p = 0.078). CONCLUSIONS LN status, age and LVI were significantly associated with survival of pT1 UCB after RC. Recurrent pT1 UCB of HGO should be managed with radical cystectomy in a timely fashion given that these cases tend to have poorer CSS than primary pT1 UCB after RC, even if they did not progress to muscle-invasive bladder cancer (MIBC).

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China

Related Publications

Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
September 2008, Urology,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
March 2013, BJU international,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
December 2011, International urology and nephrology,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
May 2012, European urology,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
September 2022, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
August 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
October 2023, Urologic oncology,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
October 2015, World journal of urology,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
August 2006, World journal of urology,
Baojie Ma, and Yu Li, and Saisai Han, and Xingkang Jiang, and Yang Zhao, and Jianing Guo, and Changyi Quan, and Yuanjie Niu
September 2022, World journal of urology,
Copied contents to your clipboard!